Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KSPI | JOINT STOCK CO KASPIKZ | $22.14B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2024-05-22 | |
| APGE | APOGEE THERAPEUTICS INC | $2.64B | $0.00 | -$83.90M | -$83.99M | -$3.36 | N/A | N/A | N/A | N/A | ||
| STNG | SCORPIO TANKERS INC | $3.80B | $1.34B | $932.63M | $546.90M | $10.44 | -14.18% | 18.05% | -9.14% | N/A | 2024-05-09 | |
| DNLI | DENALI THERAPEUTICS INC | $2.34B | $330.53M | -$128.47M | -$145.22M | -$1.06 | 204.74% | 20.67% | N/A | N/A | 2024-05-06 | |
| HLVX | HILLEVAX INC | $696.81M | $0.00 | -$119.02M | -$123.57M | -$3.04 | N/A | N/A | N/A | N/A | 2024-06-05 | |
| ABUS | ARBUTUS BIOPHARMA CORP | $505.76M | $12.99M | -$72.66M | -$74.39M | -$0.44 | -60.80% | 20.14% | N/A | N/A | ||
| RCUS | ARCUS BIOSCIENCES INC | $1.41B | $117.00M | -$285.00M | -$307.00M | -$4.15 | 4.46% | 69.54% | N/A | N/A | 2024-05-08 | |
| TNYA | TENAYA THERAPEUTICS INC | $362.74M | $0.00 | -$112.27M | -$124.08M | -$1.68 | N/A | N/A | N/A | N/A | 2024-05-08 | |
| KMPR | KEMPER CORP | $3.76B | $4.79B | $240.20M | -$120.70M | -$1.89 | -12.04% | 2.34% | N/A | N/A | ||
| MGM | MGM RESORTS INTERNATIONAL | $12.82B | $16.67B | $2.69B | $892.85M | $2.62 | 17.87% | 6.59% | -44.84% | 41.01% | ||
| FLEX | FLEX LTD | $11.55B | $29.39B | $1.43B | $753.00M | $1.71 | -1.12% | 2.17% | -5.00% | 46.90% | ||
| ROST | ROSS STORES INC | $42.80B | $20.38B | $2.73B | $1.87B | $5.59 | 8.99% | 6.34% | 27.05% | 5.39% | 2024-05-22 | |
| ANRO | ALTO NEUROSCIENCE INC | $387.13M | $0.00 | -$34.28M | -$36.31M | -$9.73 | N/A | N/A | N/A | N/A | ||
| EWTX | EDGEWISE THERAPEUTICS INC | $1.80B | $0.00 | -$98.43M | -$100.16M | -$1.57 | N/A | N/A | N/A | N/A | 2024-06-07 | |
| GOSS | GOSSAMER BIO INC | $173.92M | $0.00 | -$161.92M | -$179.82M | -$1.18 | N/A | N/A | N/A | N/A | 2024-05-07 | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $207.55M | $3.60M | -$99.57M | -$117.17M | -$11.60 | N/A | 17.43% | N/A | N/A | 2024-06-07 | |
| NOTE | FISCALNOTE HOLDINGS INC | $176.86M | $132.65M | -$80.69M | -$115.46M | -$0.88 | 16.60% | N/A | N/A | N/A | 2024-05-08 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.